Cognex (NASDAQ:CGNX) Earns “Underweight” Rating from JPMorgan Chase & Co.

Cognex (NASDAQ:CGNX)‘s stock had its “underweight” rating restated by analysts at JPMorgan Chase & Co. in a research report issued on Wednesday,Benzinga reports. They currently have a $35.00 target price on the scientific and technical instruments company’s stock, down from their previous target price of $45.00. JPMorgan Chase & Co.‘s target price indicates a potential downside of 8.35% from the stock’s current price.

A number of other equities analysts have also recently weighed in on CGNX. UBS Group reaffirmed a “buy” rating and issued a $58.00 price target on shares of Cognex in a report on Friday, October 31st. DA Davidson set a $38.00 price objective on shares of Cognex and gave the company a “neutral” rating in a research note on Monday, November 3rd. Needham & Company LLC raised their target price on Cognex from $45.00 to $47.00 and gave the stock a “buy” rating in a research note on Friday, October 31st. Robert W. Baird set a $45.00 price target on shares of Cognex in a report on Friday, October 31st. Finally, The Goldman Sachs Group boosted their price objective on shares of Cognex from $36.00 to $40.00 and gave the company a “sell” rating in a report on Tuesday, September 16th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $45.53.

Cognex Price Performance

Shares of Cognex stock opened at $38.19 on Wednesday. The firm has a fifty day moving average price of $42.36 and a 200 day moving average price of $38.73. The stock has a market cap of $6.40 billion, a PE ratio of 59.67 and a beta of 1.53. Cognex has a 1 year low of $22.67 and a 1 year high of $49.76.

Cognex (NASDAQ:CGNX) last issued its earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.06. Cognex had a return on equity of 8.26% and a net margin of 11.33%.The firm had revenue of $264.00 million for the quarter, compared to the consensus estimate of $261.86 million. During the same quarter in the prior year, the business earned $0.20 earnings per share. The company’s revenue was up 18.0% compared to the same quarter last year. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. As a group, equities analysts expect that Cognex will post 0.61 EPS for the current year.

Insiders Place Their Bets

In other Cognex news, Director Robert Willett sold 6,704 shares of the stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total value of $331,915.04. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Sheila Marie Dipalma sold 2,002 shares of Cognex stock in a transaction on Friday, September 5th. The stock was sold at an average price of $45.00, for a total transaction of $90,090.00. Following the sale, the executive vice president owned 8,582 shares in the company, valued at $386,190. This represents a 18.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 10,706 shares of company stock valued at $512,065. Insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Quent Capital LLC acquired a new position in shares of Cognex in the 3rd quarter valued at $26,000. REAP Financial Group LLC acquired a new stake in shares of Cognex in the 3rd quarter valued at approximately $27,000. Geneos Wealth Management Inc. lifted its holdings in Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 736 shares during the period. Penserra Capital Management LLC purchased a new stake in Cognex during the second quarter worth about $29,000. Finally, TD Waterhouse Canada Inc. purchased a new stake in shares of Cognex during the 2nd quarter worth approximately $29,000. Institutional investors and hedge funds own 88.12% of the company’s stock.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.